We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$9.13B
AUM Growth
+$334M
Cap. Flow
-$281M
Cap. Flow %
-3.08%
Top 10 Hldgs %
21.52%
Holding
2,368
New
73
Increased
154
Reduced
1,152
Closed
75

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.6M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$3.94M
3
CZR icon
Caesars Entertainment
CZR
+$3.71M
4
IAA
IAA, Inc. Common Stock
IAA
+$3.57M
5
RUN icon
Sunrun
RUN
+$3.42M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$22.2M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$15.9M
3
MSFT icon
Microsoft
MSFT
+$13.6M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$9.6M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$9.15M

Sector Composition

Rank Sector Weight
1 Technology 22.17%
2 Healthcare 13.84%
3 Financials 12.41%
4 Consumer Discretionary 11.36%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TECX
1901
Tectonic Therapeutic
TECX
$699M
$187K ﹤0.01%
1,199
– –
CFB
1902
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$187K ﹤0.01%
21,534
– –
PHAT icon
1903
Phathom Pharmaceuticals
PHAT
$740M
$187K ﹤0.01%
5,088
– –
PRSU
1904
Pursuit Attractions and Hospitality Inc
PRSU
$1.28B
$186K ﹤0.01%
8,932
– –
CVM icon
1905
CEL-SCI Corp
CVM
$25.5M
$186K ﹤0.01%
486
– –
NGM
1906
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$186K ﹤0.01%
11,665
– –
BMRC icon
1907
Bank of Marin Bancorp
BMRC
$466M
$185K ﹤0.01%
6,398
– –
UVE icon
1908
Universal Insurance Holdings
UVE
$1.18B
$185K ﹤0.01%
13,371
– –
HY icon
1909
Hyster-Yale Materials Handling
HY
$616M
$185K ﹤0.01%
4,976
– –
MSGN
1910
DELISTED
MSG Networks Inc.
MSGN
$183K ﹤0.01%
19,156
– –
PRTA icon
1911
Prothena Corp
PRTA
$472M
$183K ﹤0.01%
18,324
– –
DBD
1912
DELISTED
Diebold Nixdorf Incorporated
DBD
$183K ﹤0.01%
23,958
-11,477
-32% -$84.4K
KOS icon
1913
Kosmos Energy
KOS
$1.48B
$182K ﹤0.01%
186,480
– –
GTHX
1914
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$181K ﹤0.01%
15,694
– –
MORF
1915
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$181K ﹤0.01%
6,630
– –
APEI icon
1916
American Public Education
APEI
$844M
$181K ﹤0.01%
6,422
– –
ARDX icon
1917
Ardelyx
ARDX
$1.01B
$181K ﹤0.01%
34,441
-2,566
-7% -$15.4K
GSBC icon
1918
Great Southern Bancorp
GSBC
$882M
$181K ﹤0.01%
4,991
– –
CNSL
1919
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$180K ﹤0.01%
31,722
– –
AXGN icon
1920
Axogen
AXGN
$2.62B
$180K ﹤0.01%
15,476
– –
THFF icon
1921
First Financial Corp
THFF
$976M
$179K ﹤0.01%
5,707
– –
LGTY
1922
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$179K ﹤0.01%
12,761
– –
DVAX
1923
DELISTED
Dynavax Technologies
DVAX
$179K ﹤0.01%
41,452
– –
IIIV icon
1924
i3 Verticals
IIIV
$318M
$179K ﹤0.01%
7,082
– –
AMTI
1925
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$179K ﹤0.01%
+5,614
New +$138K
75 76
77
78 79

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return

MetLife Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, MetLife Investment Management held 2,368 positions worth $9.13B, up 3.8% from $8.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management withdrew a net $281M in Q3 2020, closing 75 positions and reducing 1,152 holdings. Its most notable exit was Slack Technologies, Inc., an estimated $7.44M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Jazz Pharmaceuticals worth $4.53M.

  • MetLife Investment Management's largest Q3 2020 buy was Jazz Pharmaceuticals: 31,753 shares worth $4.53M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $34.6M increase.
  • MetLife Investment Management's biggest Q3 2020 reduction was Apple, cutting an estimated $22.2M.
  • MetLife Investment Management fully exited Slack Technologies, Inc. in Q3 2020, selling an estimated $7.44M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $9.13B portfolio in Q3 2020.
  • MetLife Investment Management opened 73 new positions and closed 75 in Q3 2020.
  • MetLife Investment Management's portfolio value rose 3.8% quarter-over-quarter to $9.13B.

Based on MetLife Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.